IMDXInsight Molecular Diagnostics Inc.

IMDX Stock Price, Valuation & Chart | Insight Molecular Diagnostics Inc.

Compare

$4.010+0.17 (+4.43%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology IMDX intrinsic value IMDX calculated fair value vs price

Overview Financials Dividends Ratios

IMDX Historical price chart

IMDX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization129.48M

PE Ratio-2.69

EPS-1.49

Trading Volume80.81K

Today's High/Low4.04/3.81

Dividend Yield0.00

52 Week High/Low8.51/2.4

Shares Outstanding32.29M

IMDX Financial Statement

IMDX Analyst ratings

IMDX Analysis & performance metrics

IMDX Company profile

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the…

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery…

IMDX Management team

Name

Position

Yuh-Min Chiang Ph.D.CTO

Chief Technology Officer

Peter Hong

Vice President, General Counsel & Secretary

James Liu

Vice President of Accounting, Treasurer, Controller & Principal Accounting Officer

Joshua RiggsCEO

President, Chief Executive Officer & Director

Ekkehard Schutz M.D., Ph.D.

Chief Science Officer

Andrea Susan JamesCFO

Chief Financial Officer

Sandra O'Donald

Senior Vice President of Business Operations

Michael D. West Ph.D.CEO

Scientific Advisor, Co-Chief Executive Officer of Biotime,Inc. & President of Biotime,Inc.

Name

Position

Yuh-Min Chiang Ph.D.CTO

Chief Technology Officer

Peter Hong

Vice President, General Counsel & Secretary

James Liu

Vice President of Accounting, Treasurer, Controller & Principal Accounting Officer

Joshua RiggsCEO

President, Chief Executive Officer & Director

Ekkehard Schutz M.D., Ph.D.

Chief Science Officer

Andrea Susan JamesCFO

Chief Financial Officer

Sandra O'Donald

Senior Vice President of Business Operations

Michael D. West Ph.D.CEO

Scientific Advisor, Co-Chief Executive Officer of Biotime,Inc. & President of Biotime,Inc.

Management Team

Yuh-Min Chiang Ph.D.CTO

Chief Technology Officer

Peter Hong

Vice President, General Counsel & Secretary

James Liu

Vice President of Accounting, Treasurer, Controller & Principal Accounting Officer

Joshua RiggsCEO

President, Chief Executive Officer & Director

Ekkehard Schutz M.D., Ph.D.

Chief Science Officer

Andrea Susan JamesCFO

Chief Financial Officer

Sandra O'Donald

Senior Vice President of Business Operations

Michael D. West Ph.D.CEO

Scientific Advisor, Co-Chief Executive Officer of Biotime,Inc. & President of Biotime,Inc.

Management

Yuh-Min Chiang Ph.D.CTO

Chief Technology Officer

Peter Hong

Vice President, General Counsel & Secretary

James Liu

Vice President of Accounting, Treasurer, Controller & Principal Accounting Officer

Joshua RiggsCEO

President, Chief Executive Officer & Director

Ekkehard Schutz M.D., Ph.D.

Chief Science Officer

Andrea Susan JamesCFO

Chief Financial Officer

Sandra O'Donald

Senior Vice President of Business Operations

Michael D. West Ph.D.CEO

Scientific Advisor, Co-Chief Executive Officer of Biotime,Inc. & President of Biotime,Inc.

Total 8 executives

IMDX Frequently asked questions

What is Insight Molecular Diagnostics Inc. (IMDX) Stock Price?

Current stock price of Insight Molecular Diagnostics Inc. (IMDX) stock is $4.010. The stock price is +4.43% higher in the session. The intraday range can be seen from this page. Volume of Insight Molecular Diagnostics Inc. (IMDX) stock is 80.81K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Insight Molecular Diagnostics Inc. (IMDX) stock price going up or down today?

The stock price of Insight Molecular Diagnostics Inc. (IMDX) can change with earnings, company news, and overall market sentiment. Insight Molecular Diagnostics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Insight Molecular Diagnostics Inc. stock expensive at its current price?

Whether Insight Molecular Diagnostics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IMDX on this page is -2.69. EPS on this page is -1.49. Compare those figures with peers and growth expectations before deciding if the current Insight Molecular Diagnostics Inc. price is justified.

How has the stock price of Insight Molecular Diagnostics Inc. (IMDX) performed historically?

Historical performance for Insight Molecular Diagnostics Inc. (IMDX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IMDX reacted to past earnings and market events.

Should I buy Insight Molecular Diagnostics Inc. (IMDX) stock, at this price?

Buying Insight Molecular Diagnostics Inc. (IMDX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.